MGX
Price
$1.23
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Capitalization
46.47M
4 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$3.55
Change
-$0.12 (-3.27%)
Updated
Aug 14 closing price
Capitalization
1.07B
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MGX vs SANA

MGX vs SANA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MGX vs. SANA commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGX is a Hold and SANA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2026
Stock price -- (MGX: $1.23 vs. SANA: $3.55)
Brand notoriety: MGX and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGX: 42% vs. SANA: 100%
Market capitalization -- MGX: $46.47M vs. SANA: $1.07B
MGX [@Biotechnology] is valued at $46.47M. SANA’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $128.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGX’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • MGX’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGX’s TA Score shows that 3 TA indicator(s) are bullish while SANA’s TA Score has 5 bullish TA indicator(s).

  • MGX’s TA Score: 3 bullish, 4 bearish.
  • SANA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SANA is a better buy in the short-term than MGX.

Price Growth

MGX (@Biotechnology) experienced а 0.00% price change this week, while SANA (@Biotechnology) price change was +0.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was +2992.28%.

Reported Earning Dates

MGX is expected to report earnings on Aug 19, 2026.

SANA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($1.07B) has a higher market cap than MGX($46.5M). SANA YTD gains are higher at: -12.776 vs. MGX (-24.074). MGX has higher annual earnings (EBITDA): -87.55M vs. SANA (-192.2M). MGX has more cash in the bank: 140M vs. SANA (101M). MGX has less debt than SANA: MGX (39.2M) vs SANA (75.3M). MGX has higher revenues than SANA: MGX (22.3M) vs SANA (0).
MGXSANAMGX / SANA
Capitalization46.5M1.07B4%
EBITDA-87.55M-192.2M46%
Gain YTD-24.074-12.776188%
P/E RatioN/AN/A-
Revenue22.3M0-
Total Cash140M101M139%
Total Debt39.2M75.3M52%
TECHNICAL ANALYSIS
Technical Analysis
MGXSANA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 23 days ago
88%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MGX
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMECX28.360.02
+0.07%
American Funds Income Fd of Amer A
HNCSX24.83N/A
N/A
Hartford International Growth R4
BISMX28.45N/A
N/A
Brandes International Small Cap Equity I
NRARX64.25-0.38
-0.59%
Neuberger Quality Equity R3
ADNIX22.79-0.45
-1.94%
American Beacon ARK Transfmt Innov R5

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with EDIT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
N/A
EDIT - MGX
47%
Loosely correlated
+0.36%
VYGR - MGX
47%
Loosely correlated
+1.55%
CRBU - MGX
47%
Loosely correlated
-1.86%
RXRX - MGX
45%
Loosely correlated
-4.53%
SANA - MGX
44%
Loosely correlated
-3.27%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with ABSI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
-3.27%
ABSI - SANA
55%
Loosely correlated
-2.96%
CRBU - SANA
55%
Loosely correlated
-1.86%
RXRX - SANA
54%
Loosely correlated
-4.53%
EDIT - SANA
52%
Loosely correlated
+0.36%
CRSP - SANA
52%
Loosely correlated
-0.81%
More